Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis

被引:82
作者
Hwang, J
Son, KN
Kim, CW
Ko, J
Na, DS
Kwon, BS
Gho, YS [1 ]
Kim, J
机构
[1] Kyung Hee Univ, Grad Sch Biotechnol, Yongin 449701, South Korea
[2] Kyung Hee Univ, Inst Life Sci & Resources, Yongin 449701, South Korea
[3] Univ Ulsan, Coll Med, Dept Biochem, Seoul 138736, South Korea
[4] Univ Ulsan, Immunomodulat Res Ctr, Ulsan 680749, South Korea
[5] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea
关键词
chemokine; CCL23; MPIF-1; MIP-3; CK beta 8; endothelial cells; angiogenesis; CCR1;
D O I
10.1016/j.cyto.2005.01.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of chemokines induce angiogenesis and endothelial cells express several chemokine receptors. To date, only a limited number of CC chemokines for CCR1 have been reported to induce angiogenic responses. We investigated the ability of CCL23 (also known as MPIF-1, MIP-3, or CK beta 8) to promote angiogenesis, which induces chemotaxis of immune cells through CCR1. CCL23 promoted the chemotactic migration and differentiation of endothelial cells, and neovascularization in the chick chorioallantoic membrane. An N-terminal truncated form of CCL23 was at least 100-fold more potent than its intact form and was comparable to that of FGF in the angiogenic activities. Treatment with either pertussis toxin or anti-CCR1 antibody completely inhibited the CCL23-induced endothelial cell migration, indicating that endothelial cell migration was mediated through CCR1. CCL23 didn't promote the migration of HT1080 human fibrosarcoma cells that did not express CCRL Our results suggest a role of CCL23 in angiogenesis in vitro as well as in vivo. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:254 / 263
页数:10
相关论文
共 35 条
[1]   Selective binding of the truncated form of the chemokine CKβ8 (25-99) to CC chemokine receptor 1 (CCR1) [J].
Berkhout, TA ;
Gohil, J ;
Gonzalez, P ;
Nicols, CL ;
Moores, KE ;
Macphee, CH ;
White, JR ;
Groot, PHE .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (05) :591-596
[2]   Analysis of the role of chemokines in angiogenesis [J].
Bernardini, G ;
Ribatti, D ;
Spinetti, G ;
Morbidelli, L ;
Ziche, M ;
Santoni, A ;
Capogrossi, MC ;
Napolitano, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 273 (1-2) :83-101
[3]   I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo [J].
Bernardini, G ;
Spinetti, G ;
Ribatti, D ;
Camarda, G ;
Morbidelli, L ;
Ziche, M ;
Santoni, A ;
Capogrossi, MC ;
Napolitano, M .
BLOOD, 2000, 96 (13) :4039-4045
[4]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF CHEMOKINES [J].
CLARKLEWIS, I ;
KIM, KS ;
RAJARATHNAM, K ;
GONG, JH ;
DEWALD, B ;
MOSER, B ;
BAGGIOLINI, M ;
SYKES, BD .
JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 57 (05) :703-711
[5]   Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties [J].
Detheux, M ;
Ständker, L ;
Vakili, J ;
Münch, J ;
Forssmann, U ;
Adermann, K ;
Pöhlmann, S ;
Vassart, G ;
Kirchhoff, F ;
Parmentier, M ;
Forssmann, WG .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) :1501-1508
[6]   Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines [J].
Feil, C ;
Augustin, HG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (01) :38-45
[7]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
[8]   CK beta 8, a novel CC chemokine that predominantly acts on monocytes [J].
Forssmann, U ;
Delgado, MB ;
Uguccioni, M ;
Loetscher, P ;
Garotta, G ;
Baggiolini, M .
FEBS LETTERS, 1997, 408 (02) :211-216
[9]   RANTES and MCP-3 antagonists bind multiple chemokine receptors [J].
Gong, JH ;
Uguccioni, M ;
Dewald, B ;
Baggiolini, M ;
ClarkLewis, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) :10521-10527
[10]   ANTAGONISTS OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 IDENTIFIED BY MODIFICATION OF FUNCTIONALLY CRITICAL NH2-TERMINAL RESIDUES [J].
GONG, JH ;
CLARKLEWIS, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :631-640